Calyx, an eClinical and Regulatory solutions and services provider announced the availability of Calyx Supply Simulation, a clinical trial supply forecasting service available through Calyx's in-house expert statistical design and trial supplies consultants.
Clinical trial sponsors can leverage the simulation service to inform decision-making related to the quantity of medication produced for use in clinical development. The service helps sponsors improve clinical trial efficiencies by evaluating the amount of medication required to start and maintain clinical trial enrolment, predicting how long an existing amount of study medication will last, and determining the optimal site and depot buffer stock quantities required to ensure dispensation while reducing the cost and burden of excessive drug wastage.
"We're pleased to offer this valuable service so that global clinical trial sponsors can reduce the risk of drug availability impacting their clinical studies as patients progress through the dispensing events of clinical trials," said Juan Munoz Pujol. "In addition, by optimizing supply requirements upfront with Calyx Supply Simulation, sponsors can minimize the amount of drugs that end up destroyed during clinical trials, which will reduce excessive drug wastage and help sponsors meet their corporate sustainability goals."
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!